JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,419,166 | +190648.1% | 767,117 | +14.4% | 0.00% | – |
| Q4 2022 | $744 | -100.0% | 670,462 | +2.0% | 0.00% | – |
| Q3 2022 | $1,538,000 | -18.7% | 657,282 | +5.3% | 0.00% | – |
| Q2 2022 | $1,891,000 | -53.3% | 624,275 | +4.6% | 0.00% | -100.0% |
| Q1 2022 | $4,051,000 | -22.1% | 596,615 | -4.2% | 0.00% | 0.0% |
| Q4 2021 | $5,201,000 | +13.9% | 622,876 | +1.4% | 0.00% | 0.0% |
| Q3 2021 | $4,565,000 | +26.8% | 614,430 | +16.0% | 0.00% | – |
| Q2 2021 | $3,600,000 | +2.4% | 529,515 | +54.6% | 0.00% | -100.0% |
| Q1 2021 | $3,517,000 | +88.1% | 342,525 | +28.1% | 0.00% | – |
| Q4 2020 | $1,870,000 | -12.8% | 267,307 | +1.7% | 0.00% | – |
| Q3 2020 | $2,145,000 | +26.3% | 262,940 | +6.8% | 0.00% | – |
| Q2 2020 | $1,698,000 | +44.5% | 246,144 | -0.6% | 0.00% | – |
| Q1 2020 | $1,175,000 | -74.1% | 247,528 | -52.4% | 0.00% | – |
| Q4 2019 | $4,536,000 | +510.5% | 519,920 | +132.7% | 0.00% | – |
| Q3 2019 | $743,000 | -30.4% | 223,412 | +3.6% | 0.00% | – |
| Q2 2019 | $1,067,000 | -14.0% | 215,700 | +7.8% | 0.00% | – |
| Q1 2019 | $1,240,000 | +14.2% | 200,156 | -38.0% | 0.00% | – |
| Q4 2018 | $1,086,000 | +18.8% | 322,842 | +129.3% | 0.00% | – |
| Q3 2018 | $914,000 | -0.3% | 140,783 | +17.5% | 0.00% | – |
| Q2 2018 | $917,000 | -60.2% | 119,775 | +16.1% | 0.00% | -100.0% |
| Q1 2018 | $2,306,000 | +77.9% | 103,198 | +1.5% | 0.00% | – |
| Q4 2017 | $1,296,000 | -17.9% | 101,657 | +0.4% | 0.00% | -100.0% |
| Q3 2017 | $1,578,000 | +11.5% | 101,298 | +0.4% | 0.00% | 0.0% |
| Q2 2017 | $1,415,000 | -10.0% | 100,926 | +41.0% | 0.00% | 0.0% |
| Q1 2017 | $1,573,000 | – | 71,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |